Sign inGet started

ARMER THOMAS A

Insider CIK 1413824 · MAPP Chief Scientific Officer, Director

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
MAPP MAP Pharmaceuticals, Inc. F Tax w/h2015-01-252013-01-291,034$24.75 $25.6K130,878SEC↗
MAPP MAP Pharmaceuticals, Inc. D To issuer deriv2013-03-012013-03-048,250— $00SEC↗
MAPP MAP Pharmaceuticals, Inc. D To issuer deriv2013-03-012013-03-044,500— $00SEC↗
MAPP MAP Pharmaceuticals, Inc. D To issuer deriv2013-03-012013-03-0432,500— $00SEC↗
MAPP MAP Pharmaceuticals, Inc. D To issuer deriv2013-03-012013-03-0427,500— $00SEC↗
MAPP MAP Pharmaceuticals, Inc. D To issuer deriv2013-03-012013-03-0450,000— $00SEC↗
MAPP MAP Pharmaceuticals, Inc. D To issuer deriv2013-03-012013-03-0475,000— $00SEC↗
MAPP MAP Pharmaceuticals, Inc. D To issuer deriv2013-03-012013-03-0450,000— $00SEC↗
MAPP MAP Pharmaceuticals, Inc. D To issuer deriv2013-03-012013-03-0422,526— $00SEC↗
MAPP MAP Pharmaceuticals, Inc. D To issuer deriv2013-03-012013-03-0440,847— $00SEC↗
MAPP MAP Pharmaceuticals, Inc. U Tender2013-03-012013-03-04222,676$25.00 $5.57M0SEC↗
MAPP MAP Pharmaceuticals, Inc. M Exercise deriv2013-01-262013-01-292,250— $04,500SEC↗
MAPP MAP Pharmaceuticals, Inc. M Exercise2013-01-262013-01-292,250— $0133,128SEC↗
MAPP MAP Pharmaceuticals, Inc. F Tax w/h2013-01-262013-01-29846$24.75 $20.9K132,282SEC↗
MAPP MAP Pharmaceuticals, Inc. M Exercise deriv2013-01-252013-01-292,750— $08,250SEC↗
MAPP MAP Pharmaceuticals, Inc. M Exercise2013-01-252013-01-292,750— $0131,912SEC↗
MAPP MAP Pharmaceuticals, Inc. M Exercise deriv2013-01-232013-01-2539,620— $00SEC↗
MAPP MAP Pharmaceuticals, Inc. M Exercise2013-01-232013-01-2539,620$6.39 $253.2K188,782SEC↗
MAPP MAP Pharmaceuticals, Inc. S Sale2013-01-232013-01-2559,620$24.76 $1.48M129,162SEC↗
MAPP MAP Pharmaceuticals, Inc. S Sale2012-02-142012-02-1430,999$15.62 $484.2K149,162SEC↗
MAPP MAP Pharmaceuticals, Inc. S Sale2012-02-132012-02-142,800$16.00 $44.8K180,161SEC↗
MAPP MAP Pharmaceuticals, Inc. S Sale2012-02-082012-02-1026,201$16.00 $419.2K182,961SEC↗
MAPP MAP Pharmaceuticals, Inc. S Sale2012-02-062012-02-0719,868$15.00 $298.0K209,162SEC↗
MAPP MAP Pharmaceuticals, Inc. S Sale2012-02-032012-02-07132$15.00 $2.0K229,030SEC↗
MAPP MAP Pharmaceuticals, Inc. M Exercise deriv2012-01-262012-01-272,250— $06,750SEC↗
MAPP MAP Pharmaceuticals, Inc. F Tax w/h2012-01-262012-01-27943$13.84 $13.1K229,162SEC↗
MAPP MAP Pharmaceuticals, Inc. M Exercise2012-01-262012-01-272,250— $0230,105SEC↗
MAPP MAP Pharmaceuticals, Inc. A Award deriv2012-01-252012-01-2732,500— $032,500SEC↗
MAPP MAP Pharmaceuticals, Inc. A Award deriv2012-01-252012-01-2711,000— $011,000SEC↗